Filing Details

Accession Number:
0000899243-23-019370
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-21 16:23:57
Reporting Period:
2023-09-19
Accepted Time:
2023-09-21 16:23:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1690585 Dianthus Therapeutics Inc. DNTH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1663607 Evan Peter Harwin 200 Barr Harbor Drive, Suite 400
West Conshohocken PA 19428
Yes No Yes No
1802528 Fairmount Funds Management Llc 200 Barr Harbor Drive, Suite 400
West Conshohocken PA 19428
Yes No Yes No
1830177 Tomas Kiselak 200 Barr Harbor Drive, Suite 400
West Conshohocken PA 19428
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-09-19 30,000 $13.20 1,873,833 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
Footnotes
  1. Consists of 30,000 shares of common stock purchased by Fairmount Healthcare Fund II LP ("Fund II").
  2. Consists of (i) 58,857 shares of common stock held of record by Fairmount Healthcare Fund LP ("Fund I"), (ii) 1,752,830 shares of common stock held of record by Fund II and (iii) 62,146 shares of common stock held of record by Fairmount SPV III, LLC. Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fund I and Fund II and is the Class A Member for Fairmount SPV III, LLC. The general partner of Fairmount is Fairmount Funds Management GP LLC ("Fairmount GP"), of which Peter Harwin and Tomas Kiselak are the managing members. Fairmount, Fairmount GP, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.